Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00122629
Status:
TERMINATED
Last Update Posted:
2005-07-29
First Post:
2005-07-20
Brief Title:
Triple Therapy With Peg-Interferon Alfa-2bRibavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2bRibavirin for Previous Hepatitis C Virus HCV Non Responders
Sponsor:
Organization:
French National Agency for Research on AIDS and Viral Hepatitis